Mortality and microbiological clearance among critically ill patients receiving Polymyxin B in a Malaysian ICU: A 10 years retrospective study
Lim, A.M., N.A.Rahim, Periyasamy, P., Mat, W.R.W., Lau, C.
Published in International journal of infectious diseases (01.12.2020)
Published in International journal of infectious diseases (01.12.2020)
Get full text
Journal Article
Reassessing Locus-Specific DNA Methylation in Head-and-Neck Squamous Cell Carcinoma (HNSCC) With Quantitative Methodology and Correlation With Patient Outcome
Lim, A.M, Candiloro, I.L.M, Wong, N, Collins, M, Do, H, Angel, C, Corry, J, Rischin, D, Solomon, B, Dobrovic, A
Published in International journal of radiation oncology, biology, physics (01.02.2014)
Published in International journal of radiation oncology, biology, physics (01.02.2014)
Get full text
Journal Article
Differential Mechanisms of CDKN2A (p16) Inactivation in Oral Tongue Squamous Cell Carcinomas and Correlation With Patient Outcome
Lim, A.M, Do, H, Young, R.J, Wong, S.Q, Angel, C, Collins, M, Corry, J, Rischin, D, Dobrovic, A, Solomon, B
Published in International journal of radiation oncology, biology, physics (01.02.2014)
Published in International journal of radiation oncology, biology, physics (01.02.2014)
Get full text
Journal Article
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
Gross, Neil D., Miller, David M., Khushalani, Nikhil I., Divi, Vasu, Ruiz, Emily S., Lipson, Evan J., Meier, Friedegund, Su, Yungpo B., Swiecicki, Paul L., Atlas, Jennifer, Geiger, Jessica L., Hauschild, Axel, Choe, Jennifer H., Hughes, Brett G.M., Schadendorf, Dirk, Patel, Vishal A., Homsi, Jade, Taube, Janis M., Lim, Annette M., Ferrarotto, Renata, Kaufman, Howard L., Seebach, Frank, Lowy, Israel, Yoo, Suk-Young, Mathias, Melissa, Fenech, Keilah, Han, Hyunsil, Fury, Matthew G., Rischin, Danny
Published in The New England journal of medicine (27.10.2022)
Published in The New England journal of medicine (27.10.2022)
Get full text
Journal Article
Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)
Rischin, D., Khushalani, N.I., Schmults, C.D., Guminski, A., Chang, A.L.S., Lewis, K.D., Lim, A.M., Hernandez-Aya, L., Hughes, B.G.M., Schadendorf, D., Hauschild, A., Stankevich, E., Booth, J., Li, S., Chen, Z., Desai, J., Lowy, I., Fury, M.G., Migden, M.R.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti–PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)
Rischin, D., Lim, A.M., Schmults, C.D., Khushalani, N.I., Hughes, B.G., Schadendorf, D., Dunn, L.A., Chang, A.L.S., Hauschild, A., Ulrich, C., Eigentler, T., Migden, M.R., Pavlick, A.C., Geiger, J., Stankevich, E., Li, S., Lowy, I., Fury, M.G., Guminski, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1318P - Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti–PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)
Rischin, D., Lim, A.M., Schmults, C.D., Khushalani, N.I., Hughes, B.G., Schadendorf, D., Dunn, L.A., Chang, A.L.S., Hauschild, A., Ulrich, C., Eigentler, T., Migden, M.R., Pavlick, A.C., Geiger, J., Stankevich, E., Li, S., Lowy, I., Fury, M.G., Guminski, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress
Bhatia, S., Davar, D., Thomas, S., Silk, A.W., Wu, R.C., Ladwa, R., Park, S.J., Kelly, C.M., Wong, D.J., Grewal, J., Vohra, N., Lim, A.M., Puegero, J., Verschraegen, C., Zhong, B., Lowy, I., Fury, M., Cristea, M.
Published in EJC skin cancer (2024)
Published in EJC skin cancer (2024)
Get full text
Journal Article
A-331 - Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress
Bhatia, S., Davar, D., Thomas, S., Silk, A.W., Wu, R.C., Ladwa, R., Park, S.J., Kelly, C.M., Wong, D.J., Grewal, J., Vohra, N., Lim, A.M., Puegero, J., Verschraegen, C., Zhong, B., Lowy, I., Fury, M., Cristea, M.
Published in EJC skin cancer (2024)
Published in EJC skin cancer (2024)
Get full text
Journal Article